Abstract. In order to clarify the intracellular localization of salivary peptide P-C-like immunoreactivity in human pancreatic B-cells, an immunohistochemical study at electron microscopic levels was carried out by the protein A-gold technique using antisera against insulin and salivary peptide P-C. Both salivary peptide P-C-like immunoreactivity and insulin-like immunoreactivity were present only in the insulin secretory granules of the pancreatic B-cells. However, the former immunoreactivity was lacking in many insulin secretory granules of foetal pancreatic B-cells while the latter immunoreactivity was seen in all insulin secretory granules. Salivary peptide P-C-like immunoreactivity was not found in the other kinds of cells in the islets. In a previous immunohistochemical study at light microscopic level, salivary peptide P-C-like immunoreactivity appeared in a few pancreatic B-cells at about the 16th week of gestation, in an increasing number during gestation, and was seen in all pancreatic B-cells a few months after birth. The present finding together with the above results suggest that absence of salivary peptide P-C-like immunoreactivity in some foetal pancreatic B-cells may be due to the underdevelopment of salivary peptide P-C-like immunoreactivity in each insulin secretory granule. From the examination of cross-reactivity of antisera against salivary peptide P-C to other kinds of salivary peptides and salivary Protein C, and from the results of an indirect immunofluorescence technique using three kinds of antisera including antisera against salivary peptide P-C, salivary peptide P-B and salivary Protein C, it was thought that salivary peptide P-C-like immunoreactivity in human pancreatic B-cells belongs neither to salivary Protein C nor to salivary peptide P-B nor to salivary peptide P-E, but either to salivary peptide P-C itself or to an unknown substance which has common antigenic determinants with salivary peptide P-C, salivary peptide P-B and salivary Protein C. Salivary peptide P-C-like immunoreactivity was not found in the pancreatic B-cells of other mammals. Thus, although a new substance other than insulin is present in the insulin secretory granules of the human pancreatic B-cells, its pathophysiological function remains unclear.
vity was seen in all insulin secretory granules. Salivary peptide P-C-like immunoreactivity was not found in the other kinds of cells in the islets. In a previous immunohistochemical study at light microscopic level, salivary peptide P-C-like immunoreactivity appeared in a few pancreatic B-cells at about the 16th week of gestation, in an increasing number during gestation, and was seen in all pancreatic B-cells a few months after birth. The present finding together with the above results suggest that absence of salivary peptide P-C-like immunoreactivity in some foetal pancreatic B-cells may be due to the underdevelopment of salivary peptide P-C-like immunoreactivity in each insulin secretory granule. From the examination of cross-reactivity of antisera against salivary peptide P-C to other kinds of salivary peptides and salivary Protein C, and from the results of an indirect immunofluorescence technique using three kinds of antisera including antisera against salivary peptide P-C, salivary peptide P-B and salivary Protein C, it was thought that salivary peptide P-C-like immunoreactivity in human pancreatic B-cells belongs neither to salivary Protein C nor to salivary peptide P-B nor to salivary peptide P-E, but either to salivary peptide P-C itself or to an unknown substance which has common antigenic determinants with salivary peptide P-C, salivary peptide P-B and salivary Protein C. Salivary peptide P-C-like immunoreactivity was not found in the pancreatic B-cells of other mammals. Thus, although a new substance other than insulin is present in the insulin secretory granules of the human pancreatic B-cells, its pathophysiological function remains unclear.
Isemura et al. (1979) recently isolated salivary pep¬ tide P-C from human whole saliva and presented the primary structure of the peptide (Isemura et al. 1980 ). An immunohistochemical study using antisera against salivary peptide P-C revealed that salivary peptide P-C-like immunoreactivity was present not only in the serous cells of the human salivary glands but also in human pancreatic B-cells (Ito et al. 1983a ). As analysis of the antisera by radioimmunoassay and immunohistochemistry showed that the antisera against salivary peptide P-C did not have any cross-reactivities to insulin, human c-peptide, glucagon, somatostatin, pancrea¬ tic polvpeptide, VIP and other well known pep¬ tides, it was considered that salivary peptide P-Clike immunoreactivity was present in the human pancreatic B-cells independently from insulin and proinsulin.
To elucidate the intracellular localization of sali¬ vary peptide P-C-like immunoreactivity in the hu¬ man pancreatic B-cells, an immunohistochemical study at electron microscopic level using both antisera against insulin and salivary peptide P-C was carried out on the foetal pancreas. Furthermore, to determine whether this peptide-like immunore¬ activity was present in the pancreas of various mammals or not and to examine whether this immunoreactivity belongs either to salivary Protein C or to the other salivary peptides, an indirect immunofluroescence technique using three kinds of antisera including antisera against salivary Pro¬ tein C, antisera against salivary peptide P-C and antisera against salivary peptide P-B was carried out on human parotid glands and pancreas.
Materials and Methods

Antisera
Antisera against salivary peptide P-C (P-C antisera) were raised in rabbits by injections of isolated salivary peptide P-C-BSA conjugates which had been prepared from isolated salivary peptide P-C and BSA using glutaraldehyde. Details of the conjugation method and immunizing procedure have been reported previously (Ito et al. 1983a,b Cells reacting with P-C antisera (1A) and cells reacting with Protein C antisera pre-absorbed with salivary peptide P-C (IB) in the human parotid glands (X 120). Many of the former cells were identical to the latter cells. Cells reacting with P-C antisera which were not immunostained with Protein C antisera seemed to belong to cells containing salivary peptide P-B. Although cells reacting with P-C antisera (IC) were found in the pancreatic islets, no cells in the human pancreas were immunostained with Protein C antisera (ID) and P-B antisera (X 320).
The P-C antisera diluted 1:1000 were applied to thin sections on nickel grids overnight. The grids were rinsed in 0.1 M phosphate buffer pH 7.4 and then floated on drops of protein -gold complex and allowed to react for 60 min at room temperature. The sections were rinsed in distilled water and stained with 5% aqueous uranyl acetate for 10 min. The sections were rinsed once in distilled water and were then observed under the Hitachi HS-9 electron microscope. Control studies included 1 ) replacement of the primary antisera with 1:100 diluted normal rabbit serum, 2) pre-absorption of P-C antisera with 5 µg of isolated salivary peptide P-C and 3) omission of the primary antisera.
Results
Immunohistochemical study at the light microscopic levels A) Human parotid glands. Many serous cells of the parotid glands were immunostained with P-B antisera and salivary Protein C antisera. Furthermore, these cells were also immunostained with salivary Protein C antisera pre-absorbed with salivary pep¬ tide P-C as shown in Fig. IB with P-C antisera (P-C immunoreactive cells) were not found when P-C antisera pre-treated with salivary peptide P-C and salivary Protein C were used to replace the primary antisera. Although the detection of P-C immunoreactive cells was not affected by using P-C antisera pre-treated with salivary peptide P-E, about nine tenths of the P-C immunoreactive cells disappeared when P-C antisera pre-incubated with salivary peptide P-B were substituted for the primary antisera. This result suggested that P-C antisera were completely crossreactive to salivary peptide P-C and to salivary Protein C and partially cross-reactive to salivary P-B. Although detection of cells reacting with P-B antisera (P-B immunoreactive cells) was not af¬ fected when P-B antisera pre-absorbed with saliv¬ ary peptide P-C, salivary peptide P-E and salivary Protein C were substituted for the primary antisera in the immunohistochemical staining process, it was completely inhibited when P-B antisera preabsorbed with salivary peptide P-B were substi¬ tuted for the primary antisera. Cells reacting with Cells reacting with insulin antisera (2c) and those reacting with P-C antisera (2d) in the foetal pancreas at the 24th week of gestation (x 360) . About 50% of the insulin containing pancreatic B-cells possessed salivary peptide P-C-like immunoreactivity. Gold particles due to insulin-like immunoreactivity (2a) were found in all insulin secretory granules while those due to P-C-like immunoreactivity (2d) were observed in some insulin secretory granules. Many insulin secretory granules indicated by arrows lack or contain few gold particles due to salivary peptide P-C-like immunore¬ activity (X 33000). Fig. 2b . Gold particles due to P-C-like immunoreactivity were scarce or non-existent in the insulin secretory granules, as indicated by arrows (X 82 500).
suggests that the salivary peptide P-C-like im¬ munoreactivity in the human pancreas is that of a cross-reactive substance which has common antigenic determinants with salivary peptide P-C, sali¬ vary peptide P-B and salivary Protein C. In the foetal pancreas at about the 18th week of gestation, about 20% of pancreatic B-cells containing insulin were immunostained with P-C antisera. In foetal pancreas of the 24th week of gestation, about 50% of the pancreatic B-cells contained salivary peptide P-C-like immunoreactivity, as seen in Fig. 2c In our previous study (Ito et al. 1983a,b) , we speculated that salivary peptide P-C-like immuno¬ reactivity in the human pancreatic B-cells may belong to salivary Protein C, since the full sequence of salivary peptide P-C is identical with the COOHterminal 44 amino acid sequence of salivary Protein C, and two peptides, namely insulin and salivary peptide P-C immunoreactivity, which were not produced from the same precursor, were not thought to be present in the same cells. To deter¬ mine the plausibility of this speculation, an indirect immunofluroescence technique using Protein C antisera and Protein C antisera pre-incubated with salivary peptide P-C was carried out in the human parotid glands and pancreata. Although specific immunofluorescent cells were found in the parotid glands using both Protein C antisera and Protein C antisera pre-treated with salivary peptide P-C, these cells were not seen in the human pancreas by using both antisera including Protein C antisera and Protein C antisera pre-incubated with salivary peptide P-C. This finding strongly suggests that salivary peptide P-C-like immunoreactivity in the human pancreas is not salivary Protein C itself. In contrast, salivary peptide P-C-like immunoreacti¬ vity in human parotid glands immunostained with P-C antisera was identical to that with protein C antisera pre-incubated with salivary peptide P-C. This implied that salivary Protein C itself was present in the parotid gland. P-C immunoreactive cells were not found in the human pancreas when P-C antisera pre-absorbed with salivary peptide P-C, salivary peptide P-B and salivary Protein C were employed to replace the primary antisera in the immunohistochemical staining process. Fur-thermore, specific immunofiuorescent cells were not detected in the human pancreatic B-cells using P-B antisera. These results led us to consider that salivary peptide P-C-like immunoreactivity in the human pancreatic B-cells is not salivary Protein C itself but may be either salivary peptide P-C itself or unknown substances which the common antigenic determinants of salivary peptide P-C, salivary pep¬ tide P-B and salivary Protein C.
Since the physiological function of salivary pep¬ tide P-C has not yet been elucidated, it may be inappropriate to speculate about the pathophysio¬ logical role of salivary peptide P-C-like immunore¬ activity in the human pancreas. However, study of the ontogeny of salivary peptide P-C-like immuno¬ reactivity in the human pancreas (Ito et al. 1983b) Although we could not examine how many gold particles due to salivary peptide P-C-like immuno¬ reactivity were present in each insulin secretory granule of the foetal pancreatic B-cells at various stages of gestation, the lack of gold particles due to salivary peptide P-C-like immunoreactivity in many
